Inhibitors of gastric secretion: current progress.

Area of Science:

• Pharmacology
• Gastroenterology

Background:

• Peptic ulcer disease presents a significant clinical challenge.
• Gastric acid secretion plays a key role in ulcer pathogenesis.

Purpose of the Study:

• To review the therapeutic potential of novel gastric secretion inhibitors.
• To assess the clinical relevance of different classes of inhibitors.

Main Methods:

• Literature review of recent pharmacological advancements.
• Analysis of clinical data on gastric secretion inhibitors.

Main Results:

• Histamine H2-receptor antagonists demonstrate significant promise for treating peptic ulcers.
• Prostaglandins and gastro-intestinal polypeptides, while physiologically interesting, lack immediate clinical application.

Conclusions:

• Histamine H2-receptor antagonists are the leading therapeutic option for peptic ulcer diathesis.
• Other novel compounds require further investigation for future clinical use.